View All Reports Email Us

Global Liquid Biopsy Market Research Report- Forecast to 2022 Global Liquid Biopsy Market Research Report- Forecast to 2022

  • ID: MRFR/HC/0239-CRR
  • |
  • April, 2017
  • |
  • Region: Global
  • |
  • 171 pages
  • |
  • Cooked Research Reports

Global Liquid Biopsy Market Information, by Biomarker Types (Circulating Tumor Cells (Ctcs), Circulating Tumor Dna (Ctdna), Extracellular Vesicles (Evs) and Other Biomarker (Circulating Rna And Proteins), by Application (Cancer Therapeutic Application, Reproductive Health, Other Therapeutic Application), by Sample (Blood Sample, Urine Sample, Other) And End User (Hospitals and Laboratories, Academic And Research Centers, Other End Users) - Forecast to 2022


Market Synopsis of Global Liquid Biopsy market:


Market Scenario:


A liquid biopsy is a largely non-invasive, sampling and analysis of liquid state biological tissue for diagnostic and monitoring diseases such as cancer. Liquid biopsy is the direct clinical application of two advances in medical science namely human genome sequencing and rising sensitivity of detecting techniques and assays.


The global Liquid Biopsy market is currently valued at $ 3950 million and will reach $ 17,372.28 million growing at a CAGR of 28%. The growth factors responsible for this explosive growth are liquid biopsy is a comparatively painless and non-invasive technique which provides early real time high precision detection of diseases which could be used for monitoring and designing effective treatment strategies based on the real time molecular assessment for the progression of the disease. Other factors driving the liquid biopsy market are lifestyle changes and environmental factors such as rising investment in research and development and collaborations between companies and public organizations, rise in population particularly geriatric population, rising expenditure on health etc. The technique also has other advantages over traditional tissue biopsy such as potential applications to cardiovascular diseases, autoimmune diseases etc.


The restraints include the prohibitive costs associated with liquid biopsy and the differential awareness and availability between developing and the developed world. Also not all cancer patients benefit from early detection as some cancers such as brain cancer and prostate cancer may lie dormant for many years. Further liquid biopsy is not all non-invasive as can be seen in case of using spinal fluid as sample.


Global Liquid Biopsy Market, by Region 2015 (% share) 


 Liquid Biopsy Market Image


Intended Audience



  • Global Liquid Biopsy test kit manufacturers

  • Global Liquid Biopsy test kit suppliers

  • Research and development Laboratories

  • Market Research and Consulting Service Providers


Key findings



  • Circulating tumor cells (CTCs) segment dominates both in terms of market share as well as revenues, contributing approx. 55.48% of the revenue share of the liquid biopsy market.

  • On the basis of the therapeutic application, the segment for Cancer will reflect the highest growth potential, with over 82.83% of the market share by revenues. However, the urine sample segment is anticipated to witness noticeable growth.

  • The market for liquid biopsy is dominated by North America and Europe and this trend will continue. Asia-Pacific market is the fastest growing market and is expected to grow at a CAGR of 29.7% during forecasted period


Key Players for Global Liquid Biopsy market:
Guardant Health, Inc., Trovagene, Inc., RainDance Technologies, Inc., Agena Bioscience Inc. Inc., Admera Health, Biocept, Inc., Circulogene Theranostics,  Inivata Ltd.,  SAGA Diagnostics AB,  Exosome Diagnostics and others.


Segments:
Global Liquid Biopsy market has been segmented on the basis of biomarker type which comprises of circulating tumor cells (Ctcs), circulating tumor DNA (Ctdna), extracellular vesicles (Evs) and other biomarker. On the basis of application; market is segmented into cancer therapeutic application, reproductive health, and other therapeutic application. On the basis of sample; market is segmented into blood, urine and others. On the basis of end-users; market is segmented into hospitals and laboratories, academic and research centers and others.


Regional Analysis of Global Liquid Biopsy market:
Globally North America is the largest market for Global Liquid Biopsy market. Europe is the second-largest market for Global Liquid Biopsy market. However the developing regions market particularly Asia Pacific will be the fastest growing and will be the key to the future.


The report for Global Liquid Biopsy market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Table of Contents



1    Report Prologue



2    Introduction    

2.1    Scope of Study    

2.2    Research Objective    

2.3    Assumptions & Limitations    

2.3.1    Assumptions    

2.3.2    Limitations    

2.4    Market Structure    



3    Research Methodology    

3.1    Research Process    

3.2    Primary Research    

3.3    Secondary Research

    

4    Market Dynamics    

4.1    Introduction    

4.2    Drivers    

4.2.1    Comparatively painless and non-invasive technique    

4.2.2    Early real time high precision detection of diseases    

4.2.3    Useful for designing effective treatment strategies based on the real time molecular assessment for the progression of the disease    

4.2.4    Rise in cases of cancer and other diseases    

4.2.5    Lifestyle changes and environmental factors    

4.2.6    Other advantages over other techniques    

4.2.7    The recent technological advancements has increased the appeal of liquid biopsy    

4.2.8    Transferability of liquid biopsy    

4.2.9    Rising investment in research and development and collaborations between companies and public organizations    

4.2.10    Greater focus on venture capital    

4.2.11    Demographical factors    

4.3    Restraints    

4.3.1    Prohibitive costs associated with liquid biopsy    

4.3.2    Lower sensitivity for certain biomarkers    

4.3.3    Not all cancers patients benefit from early detection    

4.3.4    Liquid biopsy is not all non-invasive    

4.3.5    Differential awareness and availability between developing and developed world    

4.3.6    Issues in venture capital, startups and collaborations    

4.4    Opportunities    

4.4.1    Growing collaboration between companies has become the entrance gateway for new firms    

4.4.2    Funding from public organizations is a good strategy to reduce development costs    

4.4.3    Rise in research and development investment    

4.4.4    Developing economies provide an unserved market for liquid biopsy    

4.4.5    Growing trend of start-ups and venture investment in the field of liquid biopsy    

4.5    Challenges    

4.5.1    Information and interest gap between the investors and the developers    

4.5.2    Lack of trained professionals in developing regions    

4.5.3    Lack of standardization and transparency    



5    Market Factor Analysis    

5.1    Porter’s Five Force Analysis    

5.1.1    Bargaining Power of Buyer    

5.1.2    Bargaining Power of Supplier    

5.1.3    Threat from substitute    

5.1.4    Threat from a New Entrant    

5.1.5    Intensity of Competitive Rivalry    

5.2    Value Chain Analysis    

5.2.1    Device Manufacturers    

5.2.2    Software developers    

5.2.3    Reagent and accessory suppliers    

5.2.4    Healthcare providers    

5.2.5    Patients    



6    Liquid Biopsy Market, By Biomarker Types    

6.1    Introduction    

6.2    Circulating Tumor Cells (CTCs)    

6.3    Circulating Tumour DNA (CtDNA)    

6.4    Extracellular Vesicles (EVs)    

6.5    Other biomarker (circulating RNA and proteins)

    

7    Global Liquid Biopsy Market, By Application    

7.1    Introduction    

7.2    Cancer    

7.3    Reproductive health    

7.4    Other therapeutic application    



8    Global Liquid Biopsy Market, By Sample    

8.1    Introduction    

8.2    Blood Sample    

8.3    Urine sample    

8.4    Other sample    



9    Global Liquid Biopsy Market, by End User    

9.1    Introduction    

9.2    Hospitals and Laboratories    

9.3    Academic and Research Centres    

9.4    Other end users    56



10    Global liquid Biopsy Market, by Region    

10.1    Introduction    

10.2    North America    

10.2.1    US    

10.2.2    CANADA    

10.3    Europe    

10.3.1    Germany    

10.3.2    France    

10.3.3    U.K.    

10.3.4    Italy    

10.3.5    Spain    

10.3.6    Rest of Europe    

10.4    Asia-Pacific    

10.4.1    Japan    

10.4.2    China    

10.4.3    India    

10.4.4    Australia    

10.4.5    Korea    

10.4.6    Rest of Asia Pacific    

10.5    Middle East and Africa    

10.5.1    UAE    

10.5.2    Saudi Arabia    

10.5.3    Egypt    

10.5.4    Rest of Middle East and Africa



11    Company Profile    

11.1    Guardant Health, Inc    

11.1.1    Company Overview    

11.1.2    Product/Business Segment Overview    

11.1.3    Financial Overview    

11.1.4    Key Development    

11.1.5    SWOT Analysis    

11.2    Trovagene, Inc    

11.2.1    Company Overview    

11.2.2    Product/Business Segment Overview    

11.2.3    Financial Overview    

11.2.4    SWOT Analysis    

11.3    RainDance Technologies, Inc.    

11.3.1    Company Overview    

11.3.2    Product/Business Segment Overview    

11.3.3    Financial Overview    

11.3.4    Key Development    

11.3.5    SWOT Analysis    

11.4    Agena Bioscience Inc. Inc.    

11.4.1    Company Overview    

11.4.2    Product/Business Segment Overview    

11.4.3    Financial Overview    

11.4.4    Key Development    

11.4.5    SWOT Analysis    

11.5    Admera Health    

11.5.1    Company Overview    

11.5.2    Product/Business Segment Overview    

11.5.3    Financial Overview    

11.5.4    Key Development    

11.5.5    SWOT Analysis    

11.6    Biocept, Inc.    

11.6.1    Company Overview    

11.6.2    Product/Business Segment Overview    

11.6.3    Financial Overview    

11.6.4    Key Development    

11.7    Circulogene Theranostics    

11.7.1    Company Overview    

11.7.2    Product/Business Segment Overview    

11.7.3    Financial Overview    

11.7.4    Key Development    

11.8    Inivata Ltd    

11.8.1    Company Overview    

11.8.2    Product/Business Segment Overview    

11.8.3    Financial Overview    

11.8.4    Key Development    

11.9    SAGA Diagnostics AB    

11.9.1    Company Overview    

11.9.2    Product/Business Segment Overview    

11.9.3    Financial Overview    

11.9.4    Key Development    

11.10    Exosome Diagnostics    

11.10.1    Company Overview    

11.10.2    Product/Business Segment Overview    

11.10.3    Financial Overview    

11.10.4    Key Development    

List of Tables

TABLE 1        GLOBAL LIQUID BIOPSY MARKET BY BIOMARKER TYPE, $ MILLION (2016-2022)    

TABLE 2        CIRCULATING TUMOR CELLS (CTCS) MARKET, BY REGION, 2014-2022 ($ MILLION)    

TABLE 3        CIRCULATING TUMOUR DNA (CTDNA) MARKET, BY REGION, 2014-2022 ($ MILLION)    

TABLE 4        EXTRACELLULAR VESICLES (EVS) MARKET, BY REGION, 2014-2022 ($ MILLION)    

TABLE 5        OTHER BIOMARKER TYPE MARKET, BY REGION, 2014-2022 ($ MILLION)    

TABLE 6    GLOBAL LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)    

TABLE 7        CANCER THERAPEUTIC APPLICATION MARKET, BY REGION, 2014-2022 ($ MILLION)    

TABLE 8    REPRODUCTIVE HEALTH THERAPEUTIC APPLICATION MARKET, BY REGION, 2014-2022 ($ ILLION)    

TABLE 9        OTHER THERAPEUTIC APPLICATION MARKET, BY REGION, 2014-2022 ($ MILLION)    

TABLE 10    GLOBAL LIQUID BIOPSY MARKET BY SAMPLE, 2014-2022 ($ MILLION)    

TABLE 11    BLOOD SAMPLE MARKET, BY REGION, 2014-2022 ($ MILLION)    

TABLE 12    URINE SAMPLE MARKET, BY REGION, 2014-2022 ($ MILLION)    

TABLE 13    OTHER SAMPLE MARKET, BY REGION, 2014-2022 ($ MILLION)    

TABLE 14    GLOBAL LIQUID BIOPSY MARKET BY END USER, 2014-2022 ($ MILLION)    

TABLE 15    HOSPITALS AND LABORATORIES END USERS MARKET, BY REGION, 2014-2022 ($ MILLION)    

TABLE 16    ACADEMIC AND RESEARCH CENTERS END USERS MARKET, BY REGION, 2014-2022 ($ MILLION)    

TABLE 17    OTHER END USERS MARKET, BY REGION, 2014-2022 ($ MILLION)    

TABLE 18    GLOBAL LIQUID BIOPSY MARKET, BY REGION, 2014-2022 ($ MILLION)    

TABLE 19    NORTH AMERICALIQUID BIOPSY MARKET, BY COUNTRY, 2014-2022 ($ MILLION)    

TABLE 20    NORTH AMERICA LIQUID BIOPSY MARKET, BY BIOMARKER TYPE, 2014-2022 ($ MILLION)    

TABLE 21    NORTH AMERICA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)    

TABLE 22    NORTH AMERICA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)    

TABLE 23    NORTH AMERICA LIQUID BIOPSY MARKET BY END USERS    

TABLE 24    U.S. LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022 ($ MILLION)    

TABLE 25    U.S. LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)    

TABLE 26    U.S. LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)    

TABLE 27    U.S. LIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)    

TABLE 28    CANADA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022 ($ MILLION)    

TABLE 29    CANADA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)    

TABLE 30    CANADA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)    

TABLE 31    CANADA LIQUID BIOPSY MARKET BY END USERS, 2014-2022 ($ MILLION)    

TABLE 32    EUROPE LIQUID BIOPSY MARKET BY COUNTRY, 2014-2022 ($ MILLION)    

TABLE 33    EUROPE LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022 ($ MILLION)    

TABLE 34    EUROPE LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)    

TABLE 35    EUROPE LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)    

TABLE 36    EUROPE LIQUID BIOPSY MARKET BY END USERS, 2014-2022 ($ MILLION)    

TABLE 37    GERMANY LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022 ($ MILLION)    

TABLE 38    GERMANY LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)    

TABLE 39    GERMANY LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)    

TABLE 40    GERMANY LIQUID BIOPSY MARKET BY END USERS, 2014-2022 ($ MILLION)    

TABLE 41    FRANCE LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022 ($ MILLION)    

TABLE 42    FRANCE LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)    

TABLE 43    FRANCE LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)    

TABLE 44    FRANCE LIQUID BIOPSY MARKET BY END USERS, 2014-2022 ($ MILLION)    

TABLE 45    U.K. LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022 ($ MILLION)    

TABLE 46    U.K. LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)    

TABLE 47    U.K. LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)    

TABLE 48    U.K. LIQUID BIOPSY MARKET BY END USERS, 2014-2022 ($ MILLION)    

TABLE 49    ITALY LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022 ($ MILLION)    

TABLE 50    ITALY LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)    

TABLE 51    ITALY LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)    

TABLE 52    ITALY LIQUID BIOPSY MARKET BY END USERS, 2014-2022 ($ MILLION)    

TABLE 53    SPAIN LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022 ($ MILLION)    

TABLE 54    SPAIN LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)    

TABLE 55    SPAIN LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)    

TABLE 56    SPAIN LIQUID BIOPSY MARKET BY END USERS, 2014-2022 ($ MILLION)    

TABLE 57    REST OF EUROPE LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022 ($ MILLION)    

TABLE 58    REST OF EUROPE LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)    

TABLE 59    REST OF EUROPE LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)    

TABLE 60    REST OF EUROPE LIQUID BIOPSY MARKET BY END USERS, 2014-2022 ($ MILLION)    

TABLE 61    ASIA PACIFIC LIQUID BIOPSY MARKET BY COUNTRY, 2014-2022 ($ MILLION)    

TABLE 62    ASIA PACIFIC LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022 ($ MILLION)    

TABLE 63    ASIA PACIFIC LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)    

TABLE 64    ASIA PACIFIC LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)    

TABLE 65    ASIA PACIFIC LIQUID BIOPSY MARKET BY END USERS, 2014-2022 ($ MILLION)    

TABLE 66    JAPAN LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022 ($ MILLION)    

TABLE 67    JAPAN LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)    

TABLE 68    JAPAN LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)    

TABLE 69    JAPAN LIQUID BIOPSY MARKET BY END USERS, 2014-2022 ($ MILLION)    

TABLE 70    CHINA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022 ($ MILLION)    

TABLE 71    CHINA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)    

TABLE 72    CHINA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)    

TABLE 73    CHINA LIQUID BIOPSY MARKET BY END USERS, 2014-2022 ($ MILLION)    

TABLE 74    INDIA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022 ($ MILLION)    

TABLE 75    INDIA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)    

TABLE 76    INDIA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)    

TABLE 77    INDIA LIQUID BIOPSY MARKET BY END USERS, 2014-2022 ($ MILLION)    

TABLE 78    AUSTRALIA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022 ($ MILLION)    

TABLE 79    AUSTRALIA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)    

TABLE 80    AUSTRALIA LIQUID BIOPSY MARKET BY END USERS, 2014-2022 ($ MILLION)    

TABLE 81    REPUBLIC OF KOREA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022 ($ MILLION)    

TABLE 82    REPUBLIC OF KOREA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)    

TABLE 83    REPUBLIC OF KOREA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)    

TABLE 84    REPUBLIC OF KOREA LIQUID BIOPSY MARKET BY END USERS, 2014-2022 ($ MILLION)    

TABLE 85    REST OF ASIA PACIFIC LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022 ($ MILLION)    

TABLE 86    REST OF ASIA PACIFIC LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)    

TABLE 87    REST OF ASIA PACIFIC LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)    

TABLE 88    REST OF ASIA PACIFIC LIQUID BIOPSY MARKET BY END USERS, 2014-2022 ($ MILLION)    

TABLE 89    MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY COUNTRY, 2014-2022 ($ MILLION)    

TABLE 90    MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022 ($ MILLION)    

TABLE 91    MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)    

TABLE 92    MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)    

TABLE 93    MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY END USERS, 2014-2022 ($ MILLION)    

TABLE 94    UAE LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022 ($ MILLION)    

TABLE 95    UAE LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)    

TABLE 96    UAE LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)    

TABLE 97    UAE LIQUID BIOPSY MARKET BY END USERS, 2014-2022 ($ MILLION)    

TABLE 98    SAUDI ARABIA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022 ($ MILLION)    

TABLE 99    SAUDI ARABIA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)    

TABLE 100    SAUDI ARABIA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)    

TABLE 101    SAUDI ARABIA LIQUID BIOPSY MARKET BY END USERS, 2014-2022 ($ MILLION)    

TABLE 102    EGYPT LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022 ($ MILLION)    

TABLE 103    EGYPT LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)    

TABLE 104    EGYPT LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)    

TABLE 105    EGYPT LIQUID BIOPSY MARKET BY END USERS, 2014-2022 ($ MILLION)    

TABLE 106    REST OF MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022 ($ MILLION)    

TABLE 107    REST OF MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)    

TABLE 108    REST OF MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)    

TABLE 109    REST OF MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY END USERS, 2014-2022 ($ MILLION)    

TABLE 110    GUARDANT HEALTH, INC: KEY DEVELOPMENT    

TABLE 111    TROVAGENE, INC CORPORATION: KEY DEVELOPMENT    

TABLE 112    RAINDANCE TECHNOLOGIES, INC. KEY DEVELOPMENT    

TABLE 113    AGENA BIOSCIENCE INC.: KEY DEVELOPMENT    

TABLE 114    ADMERA HEALTH: KEY DEVELOPMENT    

TABLE 115    BIOCEPT, INC.: KEY DEVELOPMENT    

TABLE 116    CIRCULOGENE THERANOSTICS: KEY DEVELOPMENT    

TABLE 117    INIVATA LTD: KEY DEVELOPMENT    

TABLE 118    TABLE 8: SAGA DIAGNOSTICS AB: KEY DEVELOPMENT    

TABLE 119    EXOSOME DIAGNOSTICSIS: KEY DEVELOPMENT    

List of Figures

FIGURE 1    GLOBAL LIQUID BIOPSY: MARKET STRUCTURE    

FIGURE 2    RESEARCH PROCESS OF MRFR    

FIGURE 3    GLOBAL LIQUID BIOPSY: PORTER FIVE FORCES ANALYSIS    29

FIGURE 4    GLOBAL LIQUID BIOPSY MARKET, BY BIOMARKER TYPE, MARKET SHARE 2016 (%)    

FIGURE 5    GLOBAL LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016 $ MILLION    

FIGURE 6    CIRCULATING TUMOR CELLS (CTCS) MARKET, BY REGION, 2016, $ MILLION

FIGURE 7    CIRCULATING TUMOR DNA (CTDNA) MARKET, BY REGION, 2016, $ MILLION

FIGURE 8    EXTRACELLULAR VESICLES (EVS) MARKET, BY REGION, 2016 $ MILLION    

FIGURE 9    OTHER BIOMARKER TYPE MARKET, BY REGION, 2016, ($ MILLION)    

FIGURE 10    GLOBAL LIQUID BIOPSY MARKET, BY THERAPEUTIC APPLICATIONS, MARKET SHARE 2016 (%)    

FIGURE 11    GLOBAL LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016, ($ MILLION)    

FIGURE 12    CANCER THERAPEUTIC APPLICATION MARKET, BY REGION, 2016, ($ MILLION)    

FIGURE 13    REPRODUCTIVE HEALTH THERAPEUTIC APPLICATION MARKET, BY REGION, 2016, ($ MILLION)    

FIGURE 14    OTHER THERAPEUTIC APPLICATION MARKET, BY REGION, 2016, ($ MILLION)    

FIGURE 15    GLOBAL LIQUID BIOPSY MARKET, BY SAMPLE, MARKET SHARE 2016 (%)    

FIGURE 16    GLOBAL LIQUID BIOPSY MARKET BY SAMPLE, 2016, $ MILLION    

FIGURE 17    BLOOD SAMPLE MARKET, BY REGION, 2014-2022 ($ MILLION)    

FIGURE 18    URINE SAMPLE MARKET, BY REGION, 2016, $ MILLION    

FIGURE 19    OTHER SAMPLE MARKET, BY REGION, 2016 ($ MILLION)    

FIGURE 20    GLOBAL LIQUID BIOPSY MARKET, BY END USER, MARKET SHARE 2016 (%)    

FIGURE 21    GLOBAL LIQUID BIOPSY MARKET BY END USER, 2016, $ MILLION    

FIGURE 22    HOSPITALS AND LABORATORIES END USERS MARKET BY REGION, 2016, $ MILLION    

FIGURE 23    ACADEMIC AND RESEARCH CENTERS END USERS MARKET, BY REGION, 2016, $ MILLION    

FIGURE 24    OTHER END USERS MARKET, BY REGION, 2016, $ MILLION    

FIGURE 25    GLOBAL LIQUID BIOPSY MARKET, BY REGION, MARKET SHARE 2016 (%)    

FIGURE 26    GLOBAL LIQUID BIOPSY MARKET, BY REGION, 2014-2022 ($ MILLION)    

FIGURE 27    NORTH AMERICA LIQUID BIOPSY MARKET, BY COUNTRY, MARKET SHARE 2016 (%)    

FIGURE 28    NORTH AMERICA LIQUID BIOPSY MARKET, BY BIOMARKER TYPE, 2016 ($ MILLION)    

FIGURE 29    NORTH AMERICA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016 ($ MILLION)    

FIGURE 30    NORTH AMERICA LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2016 ($ MILLION)    

FIGURE 31    NORTH AMERICALIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)    

FIGURE 32    U.S. LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016 ($ MILLION)    

FIGURE 33    U.S. LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016 ($ MILLION)

FIGURE 34    U.S. LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2016 ($ MILLION)    

FIGURE 35    U.S. LIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)    

FIGURE 36    CANADA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016 ($ MILLION)    

FIGURE 37    CANADA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016 ($ MILLION)    

FIGURE 38    CANADA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2016 ($ MILLION)    

FIGURE 39    CANADA LIQUID BIOPSY MARKET BY END USERS, 2016, ($ MILLION)    

FIGURE 40    EUROPE LIQUID BIOPSY MARKET BY COUNTRY, MARKET SHARE 2016 (%)    

FIGURE 41    EUROPE LIQUID BIOPSY MARKET BY COUNTRY, 2016 ($ MILLION)    

FIGURE 42    EUROPE LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016 ($ MILLION)    

FIGURE 43    EUROPE LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016 ($ MILLION)    

FIGURE 44    EUROPE LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2016 ($ MILLION)    

FIGURE 45    EUROPE LIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)    

FIGURE 46    GERMANY LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016 ($ MILLION)    

FIGURE 47    GERMANY LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016 ($ MILLION)    

FIGURE 48    GERMANY LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2016 ($ MILLION)    

FIGURE 49    GERMANY LIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)    

FIGURE 50    FRANCE LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016 ($ MILLION)    82

FIGURE 51    FRANCE LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016 ($ MILLION)    

FIGURE 52    FRANCE LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2016 ($ MILLION)    

FIGURE 53    FRANCE LIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)    

FIGURE 54    U.K. LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016 ($ MILLION)    

FIGURE 55    U.K. LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016 ($ MILLION)    

FIGURE 56    U.K. LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2016 ($ MILLION)    

FIGURE 57    U.K. LIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)    

FIGURE 58    ITALY LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016 ($ MILLION)    

FIGURE 59    ITALY LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016 ($ MILLION)    

FIGURE 60    ITALY LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2016 ($ MILLION)    

FIGURE 61    ITALY LIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)    

FIGURE 62    SPAIN LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016 ($ MILLION)    

FIGURE 63    SPAIN LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016 ($ MILLION)    

FIGURE 64    SPAIN LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2016 ($ MILLION)    

FIGURE 65    SPAIN LIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)    

FIGURE 66    REST OF EUROPE LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016 ($ MILLION)    

FIGURE 67    REST OF EUROPE LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016 ($ MILLION)    

FIGURE 68    REST OF EUROPE LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2016 ($ MILLION)    

FIGURE 69    REST OF EUROPE LIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)    

FIGURE 70    ASIA PACIFIC LIQUID BIOPSY MARKET BY COUNTRY, MARKET SHARE 2016 (%)    

FIGURE 71    ASIA PACIFIC LIQUID BIOPSY MARKET BY COUNTRY, 2016 ($ MILLION)    

FIGURE 72    ASIA PACIFIC LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016 ($ MILLION)    

FIGURE 73    ASIA PACIFIC LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016 ($ MILLION)    

FIGURE 74    ASIA PACIFIC LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2016 ($ MILLION)    

FIGURE 75    ASIA PACIFIC LIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)    

FIGURE 76    JAPAN LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022 ($ MILLION)    

FIGURE 77    JAPAN LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016 ($ MILLION)    

FIGURE 78    JAPAN LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2016 ($ MILLION)    

FIGURE 79    JAPAN LIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)    

FIGURE 80    CHINA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016 ($ MILLION)    

FIGURE 81    CHINA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016 ($ MILLION)    

FIGURE 82    CHINA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2016 ($ MILLION)    

FIGURE 83    CHINA LIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)    

FIGURE 84    INDIA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016 ($ MILLION)    

FIGURE 85    INDIA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016 ($ MILLION)    

FIGURE 86    INDIA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)    

FIGURE 87    INDIA LIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)    

FIGURE 88    AUSTRALIA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016 ($ MILLION)    

FIGURE 89    AUSTRALIA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016 ($ MILLION)    

FIGURE 90    AUSTRALIA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)    

FIGURE 91    AUSTRALIA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2016 ($ MILLION)    

FIGURE 92    AUSTRALIA LIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)    

FIGURE 93    REPUBLIC OF KOREA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016 ($ MILLION)    

FIGURE 94    REPUBLIC OF KOREA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016 ($ MILLION)    

FIGURE 95    REPUBLIC OF KOREA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2016 ($ MILLION)    

FIGURE 96    REPUBLIC OF KOREA LIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)    

FIGURE 97    REST OF ASIA PACIFIC LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016 ($ MILLION)    

FIGURE 98    REST OF ASIA PACIFIC LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016 ($ MILLION)    

FIGURE 99    REST OF ASIA PACIFIC LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2016 ($ MILLION)    

FIGURE 100    REST OF ASIA PACIFIC LIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)    131

FIGURE 101    MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET, MARKET SHARE BY COUNTRY, 2016 (%)    

FIGURE 102    MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY COUNTRY, 2016 ($ MILLION)    

FIGURE 103    MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016 ($ MILLION)    

FIGURE 104    MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016 ($ MILLION)    

FIGURE 105    MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2016 ($ MILLION)    

FIGURE 106    MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)    

FIGURE 107    UAE LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016 ($ MILLION)    

FIGURE 108    UAE LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016 ($ MILLION)    

FIGURE 109    UAE LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2016 ($ MILLION)    

FIGURE 110    UAE LIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)    

FIGURE 111    SAUDI ARABIA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016 ($ MILLION)    

FIGURE 112    SAUDI ARABIA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016 ($ MILLION)    

FIGURE 113    SAUDI ARABIA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2016 ($ MILLION)    

FIGURE 114    SAUDI ARABIA LIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)    

FIGURE 115    EGYPT LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016 ($ MILLION)    

FIGURE 116    EGYPT LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016 ($ MILLION)    

FIGURE 117    EGYPT LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2016 ($ MILLION)    

FIGURE 118    EGYPT LIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)    

FIGURE 119    REST OF MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016 ($ MILLION)    

FIGURE 120    REST OF MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016 ($ MILLION)    

FIGURE 121    REST OF MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2016 ($ MILLION)    

FIGURE 122    REST OF MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)    

FIGURE 123    GUARDANT HEALTH, INC: SWOT ANALYSIS    

FIGURE 124    TROVAGENE, INC; RECENT FINANCIALS    

FIGURE 125    TROVAGENE, INC CORPORATION: SWOT ANALYSIS    

FIGURE 126    RAINDANCE: RECENT FINANCIAL    

FIGURE 127    RAINDANCE TECHNOLOGIES: SWOT ANALYSIS    

FIGURE 128    AGENA BIOSCIENCE INC.: SWOT ANALYSIS    

FIGURE 129    ADMERA HEALTH: SWOT ANALYSIS   

captcha
Please enter code
captcha
Please enter code

Purchase this Market Research Report

Add To Cart

Market Research Videos

Related TAGS

Related Report

Related Categories

REPORT YOU MIGHT BE INTERESTED

Contact Us

Email Us at: salesteam@marketresearchfuture.com | Reach Us at: + (646) 845 9349 (US), +44 208 133 9349 (uk)